Phase II trial of the anti-prostate specific membrane antigen (PSMA) monoclonal antibody (mAb) J591 plus low-dose interleukin-2 (IL-2) in patients (pts) with recurrent prostate cancer (PC) Meeting Abstract

  

Authors:	Jeske, S. J.; Milowsky, M. I.; Smith, C. R.; Smith, K. A.; Bander, N. H.; Nanus, D. M.
Abstract Title:	Phase II trial of the anti-prostate specific membrane antigen (PSMA) monoclonal antibody (mAb) J591 plus low-dose interleukin-2 (IL-2) in patients (pts) with recurrent prostate cancer (PC)
Meeting Title:	43rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	25
Issue:	18 Suppl.
Meeting Dates:	2007 Jun 1-5
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2007-06-20
Start Page:	654s
Language:	English
ACCESSION:	WOS:000455043704061
PROVIDER:	wos
DOI:	10.1200/jco.2007.25.18_suppl.15558
Notes:	Meeting Abstract: 15558 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/141640